Patents by Inventor Neil Stewart Ryder

Neil Stewart Ryder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for Increasing the Susceptibility of Peptide Deformylase Inhibitors by Using Efflux Pump Inhibitors
    Publication number: 20090156645
    Abstract: The present invention provides methods and compositions for increasing the susceptibility of PDF inhibitors against Gram-negative organisms by using efflux pump inhibitors.
    Type: Application
    Filed: June 29, 2005
    Publication date: June 18, 2009
    Inventors: Charles Richard Dean, Neil Stewart Ryder
  • Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator
    Patent number: 6919317
    Abstract: Synergistic combinations of a squalene epoxidase inhibitor such as terbinafine and a macrolide T-cell immunomodulator or immunosuppressant such as 33-epichloro, 33-desoxyascomycin are provided, which are useful in particular in the treatment of diseases involving fungal or suspected fungal infection, for immunomodulation or immunosuppression in conditions in which fungal or suspected fungal colonisation of e.g. the skin plays a role, such as atopic dermatitis and seborrhoeic dermatitis, and in situations of fungal resistance.
    Type: Grant
    Filed: February 16, 2001
    Date of Patent: July 19, 2005
    Assignee: Novartis AG
    Inventors: Neil Stewart Ryder, Friedrich Karl Mayer
  • Pharmaceutical composition
    Publication number: 20030100517
    Abstract: Synergistic combinations of a squalene epoxidase inhibitor such as terbinafine and a macrolide T-cell immunomodulator or immunosuppressant such as 33-epichloro, 33-desoxyascomycin are provided, which are useful in particular in the treatment of diseases involving fungal or suspected fungal infection, for immunomodulation or immunosuppression in conditions in which fungal or suspected fungal colonisation of e.g. the skin plays a role, such as atopic dermatitis and seborrhoeic dermatitis, and in situations of fungal resistance.
    Type: Application
    Filed: October 9, 2002
    Publication date: May 29, 2003
    Inventors: Neil Stewart Ryder, Friedrich Karl Mayer
  • Antifungal composition
    Patent number: 5985906
    Abstract: Use of a combination of the squalene epoxidase inhibitor terbinafine and an azole 14-alpha-methyldemethylase inhibitor (fluconazole or itraconazole) in mycotic infections caused by azole-resistant fungal strains, and corresponding pharmaceutical compositions, process and method.
    Type: Grant
    Filed: November 12, 1997
    Date of Patent: November 16, 1999
    Assignee: Novartis AG
    Inventors: Josef Gottfried Meingassner, Neil Stewart Ryder
  • Use of all allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection or associated diseases
    Patent number: 5935998
    Abstract: Use of compounds of formula (I), wherein R has various significances, in free base form or in pharmaceutically acceptable salt form, as agents against H. pylori infection and associated diseases.
    Type: Grant
    Filed: January 6, 1998
    Date of Patent: August 10, 1999
    Assignee: Novartis AG
    Inventors: Ivan James Dalton Lindley, Neil Stewart Ryder